vimarsana.com

Page 15 - பல்கலைக்கழகம் ஆஃப் டெக்சாஸ் மருத்துவ கிளை இல் கால்வெஸ்டன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

IGM Biosciences Announces Expansion of IgM Platform into

Preclinical research reveals that new IgM antibodies administered intranasally to fight COVID-19 more potent than commonly used ones

A nasal therapy, built upon on the application of a new engineered IgM antibody therapy for COVID-19, was more effective than commonly used IgG antibodies at neutralizing the COVID-19 virus in animal models, according to research recently published by The University of Texas Health Science Center at Houston (UTHealth), The University of Texas Medical Branch at Galveston (UTMB Health), the University of Houston, and IGM Biosciences, Inc.

Graduating Student Researcher Off to Doctoral Program to Study Viruses

Six graduating seniors in Cal State Fullerton’s National Institutes of Health-funded Maximizing Access to Research Careers (MARC) program are heading to graduate programs in the fall. Six graduating seniors in Cal State Fullerton’s National Institutes of Health-funded Maximizing Access to Research Careers (MARC) program are heading to graduate programs in the fall.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.